Results 181 to 190 of about 6,836,441 (345)

Outcome in children with purpura fulminans: Report on 16 patients [PDF]

, 2005
Aytemiz Gürgey, Selin Aytaç, G Kanra, G Seçmeer, Mehmet Ceyhan, Çiğdem Altay   +5 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

PHP37 USING PATIENT REPORTED OUTCOMES (PRO) DATA TO SEGMENT HEALTH CARE CONSUMERS AND UNCOVER THEIR RECEPTIVENESS TO PHARMACEUTICAL ADVERTISING

, 2003
Mary Edmondson, Diana D. McDonnell
openalex   +1 more source

An acute problem? A report of the National Confidential Enquiry into Patient Outcome and Death [PDF]

, 2005
Sheila Adam, Mandy Odell
openalex   +1 more source

Impact of Radiotherapy on Complications and Patient-Reported Outcomes After Breast Reconstruction

Journal of the National Cancer Institute, 2018
R. Jagsi, Adeyiza O. Momoh, Ji Qi, J. Hamill, Jessica I Billig, Hyungjin Kim, A. Pusic, E. Wilkins   +7 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management. [PDF]

Health Serv Insights
Bollinger A, Hersberger KE, Gianora J, Urdieux IO, Meyer Zu Schwabedissen HE, Rommers N, Schwenkglenks M, Stäuble CK, Allemann SS.   +8 more
europepmc   +1 more source

PCN29: DEVELOPING A MEASUREMENT STRATEGY FOR PATIENT-REPORTED OUTCOMES: FINDINGS FROM THE NCI'S CANCER OUTCOMES MEASUREMENT WORKING GROUP

, 2003
C. Snyder, Justina Lipscomb, CC Gotay
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Aesthetics and Patient-Reported Outcomes in Periodontology and Implant Dentistry: Consensus Report. [PDF]

J Clin Periodontol
Tonetti M, Sanz M, Cairo F, Nart J, Chapple I, Aimetti M, Aroca S, Avila-Ortiz G, Blanco J, Bujaldón A, Cavalcanti R, Cortellini P, Cosyn J, Danser M, de Sanctis M, Derks J, Dommisch H, Figuero E, Gianserra R, Graziani F, Jepsen S, Kebschull M, Lambert F, Montero E, Naenni N, Needleman I, Pilloni A, Ramanauskaite A, Roccuzzo M, Sanz-Martín I, Sanz-Sánchez I, Schwarz F, Sculean A, Stefanini M, Thoma D, Trombelli L, Valles C, West N, Zucchelli G, Zuhr O, Herrera D.   +40 more
europepmc   +1 more source